229 related articles for article (PubMed ID: 14973415)
1. Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.
Sosabowsky J; Melendez-Alafort L; Mather S
Q J Nucl Med; 2003 Dec; 47(4):223-37. PubMed ID: 14973415
[TBL] [Abstract][Full Text] [Related]
2. Peptide radiopharmaceuticals for diagnosis and therapy.
Signore A; Annovazzi A; Chianelli M; Corsetti F; Van de Wiele C; Watherhouse RN
Eur J Nucl Med; 2001 Oct; 28(10):1555-65. PubMed ID: 11685500
[TBL] [Abstract][Full Text] [Related]
3. Rationale for the use of radiolabelled peptides in diagnosis and therapy.
Koopmans KP; Glaudemans AW
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S4-10. PubMed ID: 22388630
[TBL] [Abstract][Full Text] [Related]
4. Peptide radiopharmaceuticals in diagnosis and therapy of cancer and inflammation/infection. Proceedings of the 16th IRIST (International Research Group on Immunoscintigraphy and Therapy) Congress. May 8-10, 2003.
Cancer Biother Radiopharm; 2004 Feb; 19(1):55-134. PubMed ID: 15068611
[No Abstract] [Full Text] [Related]
5. Radiopharmaceutical development of radiolabelled peptides.
Fani M; Maecke HR
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S11-30. PubMed ID: 22388624
[TBL] [Abstract][Full Text] [Related]
6. Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases.
Okarvi SM
Med Res Rev; 2004 May; 24(3):357-97. PubMed ID: 14994368
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in 99Tcm-labelled peptide-based radiopharmaceuticals: an overview.
Okarvi SM
Nucl Med Commun; 1999 Dec; 20(12):1093-112. PubMed ID: 10664991
[TBL] [Abstract][Full Text] [Related]
8. Receptor-mediated tumor targeting with radiolabeled peptides: there is more to it than somatostatin analogs.
Mariani G; Erba PA; Signore A
J Nucl Med; 2006 Dec; 47(12):1904-7. PubMed ID: 17138731
[No Abstract] [Full Text] [Related]
9. Radiolabeled peptides in diagnosis and therapy.
Weiner RE; Thakur ML
Semin Nucl Med; 2001 Oct; 31(4):296-311. PubMed ID: 11710772
[TBL] [Abstract][Full Text] [Related]
10. Radiolabelled peptides in diagnosis and therapy: an introduction.
AL-Nahhas A; Fanti S
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S1-3. PubMed ID: 22388632
[No Abstract] [Full Text] [Related]
11. Radiopharmaceuticals for scintigraphic imaging of infection and inflammation.
Boerman OC; Dams ET; Oyen WJ; Corstens FH; Storm G
Inflamm Res; 2001 Feb; 50(2):55-64. PubMed ID: 11289655
[TBL] [Abstract][Full Text] [Related]
12. Non-oncologic applications of radiolabeled peptides in nuclear medicine.
Knight LC
Q J Nucl Med; 2003 Dec; 47(4):279-91. PubMed ID: 14973420
[TBL] [Abstract][Full Text] [Related]
13. Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings.
Follacchio GA; De Feo MS; De Vincentis G; Monteleone F; Liberatore M
Curr Radiopharm; 2018; 11(1):22-33. PubMed ID: 29231149
[TBL] [Abstract][Full Text] [Related]
14. Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer.
Giblin MF; Veerendra B; Smith CJ
In Vivo; 2005; 19(1):9-29. PubMed ID: 15796153
[TBL] [Abstract][Full Text] [Related]
15. Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals.
Boerman OC; Oyen WJ; Corstens FH
Semin Nucl Med; 2000 Jul; 30(3):195-208. PubMed ID: 10928383
[TBL] [Abstract][Full Text] [Related]
16. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
Shapiro B
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776
[TBL] [Abstract][Full Text] [Related]
17. (99m)Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model.
Karczmarczyk U; Markiewicz A; Mikołajczak R; Lisiak E; Bilski M; Pietrzykowski J; Michalik J
Nucl Med Rev Cent East Eur; 2004; 7(2):107-12. PubMed ID: 15968595
[TBL] [Abstract][Full Text] [Related]
18. Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides.
Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):288-95. PubMed ID: 17043626
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy.
van Hagen PM; Breeman WA; Bernard HF; Schaar M; Mooij CM; Srinivasan A; Schmidt MA; Krenning EP; de Jong M
Int J Cancer; 2000 Aug; 90(4):186-98. PubMed ID: 10993959
[TBL] [Abstract][Full Text] [Related]
20. Development of peptide and protein based radiopharmaceuticals.
Wynendaele E; Bracke N; Stalmans S; De Spiegeleer B
Curr Pharm Des; 2014; 20(14):2250-67. PubMed ID: 24025103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
